Monoclonal antibodies in the diagnosis and treatment of carcinoma of the breast.

Abstract

In relative terms, biologic research with Mab has reached early middle age. Information on the behavior of Mab in disease of the breast is interesting--indeed, tantalizing--in many areas, but practical applications for diagnosis and treatment are not yet available. The evidence implies that it will be forthcoming.